ViiV Healthcare GmbH, Waymade B.V. secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Maraviroc ATC J05AX09 for the period 01012026 - 31032026

Germany, April 27 -- Germany based ViiV Healthcare GmbH, Waymade B.V. has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Maraviroc ATC J05AX09 for the period 01012026 - 31032026. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....